• 한국식품위생안전성학회지
• /
• 제18권3호
• /
• pp.118-124
• /
• 2003

식품으로부터 다양한 병원 미생물을 신속 검출하기 위하여 다양한 검출 원리를 이요한 키트들이 개발 시판되고 있다. 검사키트는 신속, 정확하고 간단하게 사용할 수 있으므로 검사기관이나 실험실 뿐 아니라 식품회사에서 QC 또는 QA를 수행하기 위하여 사용이 증가되고 있는 추세이다. 이에 본 연구에서는 E. coli 0157:H7의 단클론항체를 이용하여 면역크로마토글래피법에 의해 개발된 E. coli 0157:H7 검출 키트(Donga Co, Korea, D-kit)에 대한 검출감도 및 특이성을 확인하고 식품 시료에 적용 가능성을 평가하였다. 면역크로마토그래피법에 의하여 개발 시판되고 있는 Reveal E. coli 0157:H7 kit (Neogen Co., USA. R-kit)와 VIP EHEC kit(Biocontro Inc., USA. V-kit)를 비교 키트로 사용하였다. E. coli 0157:H7 표준균주를 사용하여 실시한 검출감도 확인시험 결과 R-kit 및 D-kit는 104/m/의 농도에서 양성으로 확인되었고 $10^3$/ml에서도 약한 양성 반응을 보였으나, V-lit는 $10^5$/ml농도로 검출감도가 낮았다. 또한, 배양액을 가열하여 kit에 적용하는 것이 가열하지 않은 경우보다 검출감도를 높일 수 있었다. E. coli 0157:H7 분리 22주, verotoxin 생성 E. coli 7주 E. coli 분리주 40주 중 3주를 제외한 모든 균에서 음성의 결과를 보여 특이성을 확인하였다. 세 키트에 위양성 반응을 보인 것은 E. coli 0157:H19, E. coli 0148:H18 및 Salmonella gallinarium으로 이들 혈청형과 0157:H7 사이에는 유사한 혈청학적 특성이 존재하는 것으로 추정되었다. 이상의 실험결과로 D-kit는 E. coli 0157:H7을 검출하는데 감도 및 특이성 면에서 기존 키트인 R-kit 및 V-kit와 같이 이용한 것으로 확인되었다.

• 한국축산식품학회지
• /
• 제36권2호
• /
• pp.186-193
• /
• 2016

This study aimed to inhibit Escherichia coli (E. coli) O157:H7 artificially contaminated in fresh meat using bacteriophage. Among 14 bacteriophages, the highly lytic bacteriophage BPECO19 strain was selected to inhibit E. coli O157:H7 in artificially contaminated meat samples. Bacteriophage BPECO19 significantly reduced E. coli O157:H7 bacterial load in vitro in a multiplicity of infection (MOI)-dependent manner. E. coli O157:H7 was completely inhibited only in 10 min in vitro by the treatment of 10,000 MOI BPECO19. The treatment of BPECO19 at 100,000 MOI completely reduced 5 Log CFU/cm² E. coli O157:H7 bacterial load in beef and pork at 4 and 8h, respectively. In chicken meat, a 4.65 log reduction of E. coli O157:H7 was observed at 4 h by 100,000 MOI. The treatment of single bacteriophage BPECO19 was an effective method to control E. coli O157:H7 in meat samples.

• 한국미생물·생명공학회지
• /
• 제26권2호
• /
• pp.89-95
• /
• 1998

R. sphaereides K7 및 E15-1은 혐기적 광합성조건에서 glucose를 탄소원으로 하여 배양초기 24시간 동안은 수소가스를 계속 생산하였으나, 그 이후에는 배양액에 축적된 acetic acid및 formic acid가 배양액의 pH를 4.2-4.8로 저하시켜 수소를 거의 생산하지 못하였다. 또한 배양 6일 후에도 R. sphaeroides K7 및 E15-1의 glucose의 이용율은 각각 43% 및 74%에 불과하였다. 그러나 배양액의 pH를 6.8-7.0으로 유지하면서 배양한 결과 R. sphaeroides K7및 E15-1 두 균주 모두의 수소생산율과 glucose의 이용율이 증가되어, 수소생산은 배양 10일까지도 계속 증가되었으며, glucose도 두 균주 각각 배양후 2.5일 및 4.5일 후에 완전 소비하였다. 뿐만 아니라 균체 배양액의 pH를 중성으로 유지하면서 R. sphaeroides K7 및 E15-1을 배양할 경우 균체의 표백현상이 제거되어 배양 7일 후에는 각각 균체의 bacteriochlorophyll 함량이 약 44배 및 9배 증가되었으며, 이때 균체의 농도는 각각 약 10배 및 2.4배 증가되었다. R. sphaeroides K7 및 E15-1은 혐기적 광합성조건에서 acetic, lactic, butyric 및 malic acid로 부터도, 비록 그 양이 glucose로 부터보다는 적으나, 수소를 생산하였다. 본 실험 결과로 미루어 혐기적 광합성 조건에서 R. sphaeroides K7 및 E15-1은 glucose로부터 수소를 생성할 때 NADH 산화 및 hydrogenase가 관여한 대사가 우선적으로 일어나고, 2차적으로는 이때 생성된 유기산을 전자 공여체로 광합성 작용에 의해 질소원이 존재하지 않을 때 nirogenase에 의해서 양성자(H$^{+}$)가 환원되어 수소(H$_2$)가 생성되는 것으로 생각된다.

• 한국의학물리학회지:의학물리
• /
• 제34권2호
• /
• pp.15-22
• /
• 2023

This study compared the dose calculated using the electron Monte Carlo (eMC) dose calculation algorithm employing the old version (eMC V13.7) of the Varian Eclipse treatment-planning system (TPS) and its newer version (eMC V16.1). The eMC V16.1 was configured using the same beam data as the eMC V13.7. Beam data measured using the VitalBeam linear accelerator were implemented. A box-shaped water phantom (30×30×30 cm³) was generated in the TPS. Consequently, the TPS with eMC V13.7 and eMC V16.1 calculated the dose to the water phantom delivered by electron beams of various energies with a field size of 10×10 cm². The calculations were repeated while changing the dose-smoothing levels and normalization method. Subsequently, the percentage depth dose and lateral profile of the dose distributions acquired by eMC V13.7 and eMC V16.1 were analyzed. In addition, the dose-volume histogram (DVH) differences between the two versions for the heterogeneous phantom with bone and lung inserted were compared. The doses calculated using eMC V16.1 were similar to those calculated using eMC V13.7 for the homogenous phantoms. However, a DVH difference was observed in the heterogeneous phantom, particularly in the bone material. The dose distribution calculated using eMC V16.1 was comparable to that of eMC V13.7 in the case of homogenous phantoms. The version changes resulted in a different DVH for the heterogeneous phantoms. However, further investigations to assess the DVH differences in patients and experimental validations for eMC V16.1, particularly for heterogeneous geometry, are required.

• BMB Reports
• /
• 제49권8호
• /
• pp.431-436
• /
• 2016

Human papillomavirus (HPV) is the major cause of cervical cancer, a deadly threat to millions of females. The early oncogene product (E7) of the high-risk HPV16 is the primary agent associated with HPV-related cervical cancers. In order to understand how E7 contributes to the transforming activity, we investigated the structural features of the flexible N-terminal region (46 residues) of E7 by carrying out N-15 heteronuclear NMR experiments and replica exchange molecular dynamics simulations. Several NMR parameters as well as simulation ensemble structures indicate that this intrinsically disordered region of E7 contains two transient (10-20% populated) helical pre-structured motifs that overlap with important target binding moieties such as an E2F-mimic motif and a pRb-binding LXCXE segment. Presence of such target-binding motifs in HPV16 E7 provides a reasonable explanation for its promiscuous target-binding behavior associated with its transforming activity.

• 약학회지
• /
• 제45권4호
• /
• pp.339-346
• /
• 2001

A new oxygenated monoterpene (4) was isolated from the methanol extract of the aerial part of Erechtites hieracifolia together with six known components, a dimethylheptane (1), three ionone derivatives (2, 3 and 7) and two phenylpropanoids (5 and 6). Their structures were identified by means of physico-chemical and spectral data to be (2E, 5E)-6-hydroxy-2,6-dimethylhepta-2,4-dienal (1), 3(R)-hydroxy-5,6-epoxy-$\beta$-ionone (2), 3(R)-hydroxy-5,6-epoxy-7-ionol (3), (3E, 6E)-3,7-dimethylocta-3,5-dien-1,2,7-triol(4), 2-hydroxy-4-(2-propenyl)phenyl-$\beta$-D-glucopyranoside (5), 2-methoxy-4-(2-propenyl)phenyl -$\beta$-D-glucopyra-noside (6) and (6R, 9R)-3-oxo-$\beta$-ionol-$\alpha$-D -glucopyranoside (7).

• Molecules and Cells
• /
• 제39권2호
• /
• pp.129-135
• /
• 2016

Eukaryotic translation initiation factor 2 alpha ($eIF2{\alpha}$), which is a component of the eukaryotic translation initiation complex, functions in cell death and survival under various stress conditions. In this study, we investigated the roles of $eIF2{\alpha}$ phosphorylation in cell death using the breast cancer cell lines MCF-7 and MCF-7/ADR. MCF-7/ADR cells are MCF-7-driven cells that have acquired resistance to doxorubicin (ADR). Treatment of doxorubicin reduced the viability and induced apoptosis in both cell lines, although susceptibility to the drug was very different. Treatment with doxorubicin induced phosphorylation of $eIF2{\alpha}$ in MCF-7 cells but not in MCF-7/ADR cells. Basal expression levels of Growth Arrest and DNA Damage 34 (GADD34), a regulator of $eIF2{\alpha}$, were higher in MCF-7/ADR cells compared to MCF-7 cells. Indeed, treatment with salubrinal, an inhibitor of GADD34, resulted in the upregulation of $eIF2{\alpha}$ phosphorylation and enhanced doxorubicin-mediated apoptosis in MCF-7/ADR cells. However, MCF-7 cells did not show such synergic effects. These results suggest that dephosphorylation of $eIF2{\alpha}$ by GADD34 plays an important role in doxorubicin resistance in MCF-7/ADR cells.

• BMB Reports
• /
• 제34권1호
• /
• pp.80-84
• /
• 2001

The human papillomavirus E7 protein can form a specific complex with a retinoblastoma tumor suppressor gene product (p105-Rb) that results in the release of the E2F transcription factor, which is critical for the growth-deregulation and transforming properties of the viral E7 oncoprotein. In an attempt to apply interaction between the E7 oncoprotein and a target cellular protein Rb for an in vitro screening system for drugs against human papillomavirus infection, we primarily investigated the E7Rb binding through a pull down assay and enzyme-linked immunosorbent assay. The pull down assay showed that both glutathione S-transferase-tagged E7 and His-tagged E7 immobilized on resins specifically produced complexes with bacterially expressed Rb in a dose-dependent manner, as determined by immunoblot analyses. This result coincided with that of an enzyme-linked immunosorbent assay, which is a useful system for the mass screening of potential drugs. Taken together, this screening system (based on the interaction between E7 and Rb) can be a promising system in the development of drugs against cervical cancers caused by human papillomavirus infection.

• Asian-Australasian Journal of Animal Sciences
• /
• 제19권11호
• /
• pp.1665-1670
• /
• 2006

The objective of this research was to provide the characterization and method for producing anti-E. coli O157:H7 antibodies in egg-laying hens and to determine if the antibody can restrain the proliferation of E. coli O157:H7 in-vitro. Selected antigenic fractions (whole cell, outer membrane protein and lipopolysaccharide (LPS)) from E. coli O157:H7 were injected to hens in order to produce anti-E. coli O157:H7 antibodies. The immune response and the egg yolk antibodies of laying hens against the whole cell, outer membrane protein and LPS antigens were monitored by ELISA. The level of antibodies against whole cell antigen monitored through ELISA sharply increased after the initial immunization, and it was found to be maximum on day 49 however, the level was maintained up to day 70. Antibodies (5 mg/ml) directed against the whole cell inhibited E. coli proliferation 10-13 times more than outer membrane protein or LPS. The antibody response against the whole cell antigens appeared to have higher activity in restraining the proliferation of E. coli O157:H7 than antibody against outer membrane protein or LPS. Results reflected that increasing the IgY's in the egg yolk could prevent greater economic losses due to human and animal health from pathogenic bacteria i.e. E. coli O157:H7.

• 한국양식학회지
• /
• 제11권2호
• /
• pp.241-248
• /
• 1998

Vitellogenin(VTG) 합성에 미치는 A23187의 영향을 무지개송어의 배양 간세포를 이용하여 실험을 행하였다. 간세포는 2일간 배양한 후, Estradiol-$17^{\beta}$($E_2$, $2{\times}10^{-6}$M) 및 A23187 ($10^{-7)$~$10^{-5}$M)을 첨가하여 7일간 배양하였다. 그리고, $E_2$에 의한 VTG 합성시의 A23187이 미치는 영향에 대해서도 조사하였다. A23187이 미치는 영향에 대해서도 조사하였다. A23187 ($10^{-7)$~$10^{-5}$M)의 첨가에 의해 간세포에서의 VTG 합성은 농도의 증가에 따라 감소하였다.$E_2$에 의해 합성된 VTG는 A 23187 ($10^{-5}$M)의 첨가에 의해 대조군($E_2$만의 첨가)의 약 18%로 유의하게 감소하였다. 그러나,$E_2$제거로는 대조군의 약 47% 밖에 감소되지 않았다. 이러한 결과로 보아, 세포내의 저장 Ca은 번역 단계 또는 번역 후 단계를 조절함으로써, VTG 합성을 조절하는 것으로 추정된다.